Products
Fees
Download
Promotions
Promotions
Welcome Rewards
Referral Program
US Pre-Market Options Trading
For Institutions
For Institutions
Corporate Services
Developers
Help
About
About
About Longbridge
License & Regulatory
Media Coverage
Join Us
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote List
Quote List
EVEREST MED
(01952.HK)
Last Updated 08:00:00
News
Financials
Overview
Substantial Shareholder Wei Fu Increases Shareholding in Everest Medicines Again, Marking His Second Share Purchase in 2026 and Demonstrating Long-term Confidence
Asian Corporate Newswire
·
05/15/2026 14:08
HK
01952
-0.58%
SH
588130
+0.68%
SZ
159992
+0.13%
Asian Corporate Newswire
·
05/15/2026 14:08
HK
01952
-0.58%
SH
588130
+0.68%
SZ
159992
+0.13%
Everest Medicines Director and Major Shareholder Raises Stake in Company
Tip Ranks
·
05/15/2026 07:40
HK
01952
-0.58%
SZ
159992
+0.13%
SZ
159316
0.00%
Tip Ranks
·
05/15/2026 07:40
HK
01952
-0.58%
SZ
159992
+0.13%
SZ
159316
0.00%
BOCOM International Holdings Company Reaffirms Their Buy Rating on Everest Medicines Ltd. (1952)
Tip Ranks
·
04/18/2026 13:35
HK
01952
-0.58%
Tip Ranks
·
04/18/2026 13:35
HK
01952
-0.58%
EverSea Medicines to acquire Hasten Biopharmaceuticals
Pharmaceutical Technology
·
04/09/2026 17:39
SH
512290
+0.21%
SZ
159316
0.00%
SH
516820
-0.60%
Pharmaceutical Technology
·
04/09/2026 17:39
SH
512290
+0.21%
SZ
159316
0.00%
SH
516820
-0.60%
CICC Remains a Buy on Everest Medicines Ltd. (1952)
Tip Ranks
·
04/05/2026 13:25
SZ
159849
+0.21%
SH
520690
+0.14%
SH
512010
0.00%
Tip Ranks
·
04/05/2026 13:25
SZ
159849
+0.21%
SH
520690
+0.14%
SH
512010
0.00%
Everest Medicines (SEHK:1952) Is Up 15.7% After Revenue Surges And Loss Narrows In 2025 Results - Has The Bull Case Changed?
Simplywall
·
03/30/2026 09:38
SZ
159849
+0.21%
SH
516500
+0.17%
SH
516820
-0.60%
Simplywall
·
03/30/2026 09:38
SZ
159849
+0.21%
SH
516500
+0.17%
SH
516820
-0.60%
EVEREST MED: Performance is expected to grow significantly by 142% in 2025, achieving a turnaround to profitability
36Kr
·
03/26/2026 11:32
SZ
159316
0.00%
SH
520690
+0.14%
SZ
159567
-0.44%
36Kr
·
03/26/2026 11:32
SZ
159316
0.00%
SH
520690
+0.14%
SZ
159567
-0.44%
In the performance report, EVEREST MED's annual loss narrowed to 298 million RMB, and no dividend will be distributed
AASTOCKS
·
03/26/2026 08:55
HK
01952
-0.58%
AASTOCKS
·
03/26/2026 08:55
HK
01952
-0.58%
Everest Medicines Publishes Audited 2025 Annual Results and Report
Tip Ranks
·
03/26/2026 07:07
SH
516820
-0.60%
SZ
159837
0.00%
SH
512290
+0.21%
Tip Ranks
·
03/26/2026 07:07
SH
516820
-0.60%
SZ
159837
0.00%
SH
512290
+0.21%
A Look At Everest Medicines (SEHK:1952) Valuation After Recent Share Price Pullback
Simplywall
·
03/21/2026 10:36
HK
01952
-0.58%
Simplywall
·
03/21/2026 10:36
HK
01952
-0.58%